
Join to view full profile
1325 S Cliff AveSioux Falls, SD 57105
Phone+1 605-322-7905
Fax+1 605-322-8414
Dr. Khan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wahab Khan is an internist in Sioux Falls, SD, and is affiliated with Avera McKennan Hospital and University Health Center. Dr. Khan received his medical degree from King Edward Medical University and has been in practice for 3 years. Dr. Khan specializes in hospital medicine/hospitalist.
Education & Training
Loyola University Medical CenterResidency, Pulmonary Disease and Critical Care Medicine, 2017 - 2023
Rutgers Health/Monmouth Medical CenterResidency, Internal Medicine, 2017 - 2020
King Edward Medical UniversityClass of 2015
Certifications & Licensure
OK State Medical License 2022 - 2028
CO State Medical License 2022 - 2027
KY State Medical License 2024 - 2027
SD State Medical License Active through 2027
IA State Medical License 2022 - 2026
IL State Medical License 2024 - 2026
MN State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine- Join now to see all
Publications & Presentations
PubMed
- Managing Congestive Heart Failure at Home by Transitioning From Intravenous Furosemide to a Subcutaneous Route.Muhammad Asif, Wahab J Khan, Awais Aslam, Hammad S Chaudhry, Daud Shehzad
South Dakota Medicine. 2025-03-01 - 2 citationsCurrent approach to atherosclerotic cardiovascular disease risk prediction.Wahab J Khan, Dinesh K Kalra
Future Cardiology. 2025-02-01 - Advancement in the Treatment of Recurrent Pericarditis: Exploring Innovative Therapeutic Options.Hammad S Chaudhry, Dawood Shehzad, Mustafa Shehzad, Wahab Jahangir Khan
South Dakota Medicine. 2024-10-01
Press Mentions
Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 KitSeptember 2nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
















